Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Rafael Williams

Orthopaedic Surgery Wilson, WY Medical Doctor

NPI 1225067606 CMS profile 327732

5235 Hhr Ranch Rd, Snake River Orthopedics, Wilson, WY 83014

Open in the dashboard

General payments

$9,567

67 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Rafael Williams of Wilson, WY is reported in the CMS Open Payments database as having received $9,567 across 67 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 69th percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $676 2
2024 General $109 2
2023 General $1,103 13
2022 General $4,141 21
2021 General $286 4
2020 General $1,320 7
2019 General $1,933 18

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Rafael Williams
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Rafael Williams were reported at $676. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Rafael Williams Orthopaedic Surgery median Middle half National median
2019 $1,933 $644 $140–$2,844 $163
2020 $1,320 $312 $75–$1,860 $114
2021 $286 $520 $117–$2,495 $132
2022 $4,141 $598 $128–$2,731 $149
2023 $1,103 $461 $128–$2,264 $160
2024 $109 $497 $134–$2,475 $164
2025 $676 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $5,017 34 payments
  2. Smith+Nephew, Inc. $2,150 21 payments
  3. Active Medical, LLC $2,045 5 payments
  4. Anika Therapeutics, Inc. $193 2 payments
  5. Arthrosurface Incorporated $100 1 payment
  6. DePuy Synthes Sales Inc. $39 2 payments
  7. Pfizer Inc. $11 1 payment
  8. OSSIO Inc. $11 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $4,504 8 payments
  2. Food and Beverage $2,713 56 payments
  3. Education $1,350 2 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,000 1 payment
Products named General payments · program years 2019–2025
  1. Latarjet System $1,127 2 payments
  2. Q-FIX $1,089 2 payments
  3. Regeneten $649 11 payments
  4. MULTIFIX S $246 3 payments
  5. REGENETEN Shoulder $129 2 payments
  6. Coblation Wands $127 2 payments
  7. OVOMotion $120 1 payment
  8. HEALICOIL $112 3 payments
  9. Bioinductive Implant with Arthroscopic Delivery System - Medium $105 1 payment
  10. HemiCAP Wrist $100 1 payment
  11. Other $449 13 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

497

Median for Orthopedic Surgery: 203

Drug cost

$4,806

Median for Orthopedic Surgery: $1,433

Branded share of claims

35%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 95 $2,404
Ondansetron Odt Ondansetron Brand 102 $851
Clindamycin Phos-Benzoyl Perox Clindamycin Phos/Benzoyl Perox Brand 21 $453
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 51 $285
Cyclobenzaprine Hcl Generic 84 $284
Oxycodone Hcl Generic 75 $192
Mupirocin Generic 15 $116
Tramadol Hcl Generic 36 $115
Meloxicam Generic 18 $107

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 119 billing codes

Paid by Medicare

$237,181

Of which drugs: $903

Medicare patients

425

Average age 74

Services billed

3,124

206 women, 219 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 48%
Ischemic heart disease 20%
Atrial fibrillation 15%
Osteoporosis 15%
Cancer 13%
Depression 13%
Diabetes 12%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 143 802 $69

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

67 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Wyoming

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record